BIO-KEY INTERNATIONAL INC (BKYI)
IndustrialsSnapshot 2026-07-23
Reading BKYI? Create a free portfolio, then add this holding for ongoing Reports and tracking. Track it in a free portfolio. No credit card.
Create your account →IndustrialsSnapshot 2026-07-23
Reading BKYI? Create a free portfolio, then add this holding for ongoing Reports and tracking. Track it in a free portfolio. No credit card.
Create your account →A long-form read on the 1–3 year hold thesis. Slower and deeper than the daily snapshot — it refreshes only when the evidence moves.
This investment represents a speculative growth opportunity with high risk. The current thesis state is cautious due to recent volatility and underperformance compared to industry peers.
The market appears to be pricing in a justified valuation that is cheap compared to peers. There is an expectations gap, indicating that investors may be anticipating weaker performance than what is currently being delivered.
Management has set ambitious revenue growth targets, achieving a 34% increase in the first quarter of 2026. However, the company remains loss-making, and while there is some progress in reducing net losses, overall financial performance is still weak.
The future of BKYI hinges on its ability to meet revenue growth targets and improve operating income. Additionally, the performance of key sector bellwethers will significantly influence BKYI's trajectory, as their success could provide a favorable backdrop or signal potential challenges.
Over the next 1 to 3 years, BKYI's performance will depend on management's execution and external market conditions. Not investment advice.
The most important moves since the prior daily snapshot.
Our read on the company is unchanged since the prior snapshot.
as of 2026-07-23
Specific, dated things to watch for, each with what would confirm it and what would prove it wrong.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Why it matters: Hitting this revenue target would show strong demand. It would also support management's growth plan.
Confirms:Q2 revenue reported at or above $2.8M, reflecting a 65% increase year over year.
Disproves:Q2 revenue was below $2.8M. This shows demand is weaker than expected.
Why it matters: Ending the suspension would help investors feel more confident. It would also make the stock more stable.
Confirms:Nasdaq says the company is following the listing rules again.
Disproves:Nasdaq sends more notices about not following the rules.
Why it matters: Better operating income means better cost management. It also shows a chance for profit.
Confirms:Operating income reported as positive or a smaller net loss than $(165K) in Q2.
Disproves:Operating income remains negative or net loss increases beyond $(165K) in Q2.